Apraxia Treatment Market Trends Opportunity Assessment and Forecast up to 2030

Apraxia: Neurological Disorder Characterized by Difficulty in Motor Movement

Apraxia is a neurological disorder characterized by loss of the ability to execute or carry out skilled movements and gestures, despite having the desire and the physical ability to perform them
Apraxia results from dysfunction of the cerebral hemispheres of the brain, especially the parietal lobe, and can arise from many diseases or damage to the brain. Milder forms of apraxia are known as dyspraxia.
There are several kinds of apraxia, which may occur alone or together. The most common is buccofacial or orofacial apraxia, which causes the inability to carry out facial movements on command such as licking lips, whistling, coughing, or winking.
Treatment of apraxia consists of physical, speech, and occupational therapy. If apraxia is a symptom of another disorder, the underlying disorder is treated.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Apraxia Treatment Market Report

Key Drivers and Restraints of Global Apraxia Treatment Market

Rise in prevalence of neurological disorders and growing awareness for apraxia treatment are some of the major factors responsible for the growth of global apraxia treatment market
For instance, according to the American Speech Language Hearing Association (ASHA) data, incidence of Childhood Apraxia of Speech (CAS) is 1–10 in 1000 children or 3% to 5% of speech-impaired preschoolers in the U.S.
Ongoing investigational therapy studies for apraxia is also a major factor fuelling the growth of the apraxia treatment market
Growing demand for better treatment methods for apraxia disease has further boosted the growth of global apraxia treatment market

High Cost of Treatment to Hamper Market Growth

Apraxia is one of the rare diseases which have no proper approved medications available. Treatment cost is very high due to complex mechanism for disease treatment which can hamper the market growth.
No approved drugs are available for apraxia. This is also restraining the growth of global apraxia treatment market.

Medication to be More Promising Treatment Type Segment

Based on treatment type, global apraxia treatment market can be divided into medication and supportive therapies
The medication segment dominated the global market and is expected to grow at a higher CAGR due to pipeline products and growing demand for pharmacological treatment for apraxia
The medication segment is further sub-segmented into neuromuscular blockers, antiparkinson agents, anticholinergic agents, anticonvulsants, and others
Supportive therapies consist of speech therapy, physical therapy, and occupational therapy